ImmuneOncia aims to develop immuno-oncology therapeutics

to transform the standard of care in cancer treatment

  • IR/PR
  • Disclosures

Disclosures

Submission Date Disclosure Title Author
2025-11-28 Response to Request for Inquired Disclosure (Significant Change in Stock Trading Activities) : Denial 이뮨온시아
2025-11-27 Request for Inquired Disclosure (Significant Market Fluctuations) 코스닥시장본부
2025-11-14 Quarterly Report (2025.09) 이뮨온시아
2025-08-14 Semi-annual Report (2025.06) 이뮨온시아
2025-05-30 Exercise of Stock Option 이뮨온시아
2025-05-23 Report on status of specific securities, etc. owned by executives and major shareholders 유한양행
2025-05-23 Report on significant holdings of stocks, etc. (General) 유한양행
2025-05-12 Post-issuance report 이뮨온시아
2025-04-30 [Corrected description]Prospectus 이뮨온시아
2025-04-30 [Conditions for issuance finalized]Registration Statement (Equity securities) 이뮨온시아
1 2 3